-
Market Overview: The North America Clinical Trial Supply & Logistics Market was valued at USD 1.21 billion in 2023 and is expected to grow at a CAGR of 6.81%, reaching USD 1.78 billion by 2029.
-
Market Scope: The market includes services like packaging, labeling, storage, distribution, transportation, and comparator sourcing, critical for supporting clinical trials in the pharmaceutical and biotechnology industries.
-
Key Drivers:
- Increasing Clinical Trials: The rise in clinical trials and advancements in biopharmaceutical research are driving market growth.
- Chronic Disease Prevalence: The growing prevalence of chronic diseases increases demand for clinical trial logistics.
- Technological Advancements: The adoption of innovative technologies like temperature-controlled logistics, blockchain, AI, IoT, and interactive response technologies enhances supply chain efficiency and reliability.
-
Challenges and Trends:
- Regulatory Complexities: Companies face stringent regulatory requirements and global sourcing challenges.
- Decentralized Trials: The expansion of decentralized and virtual clinical trials requires flexible and agile supply chain solutions.
-
Technological Integration:
- Blockchain: Used for enhancing transparency, traceability, and security in the supply chain.
- AI and Machine Learning: Employed for predictive analytics, optimizing demand forecasting, inventory management, and improving overall supply chain efficiency.
- IoT and Sensors: Used for real-time monitoring of temperature-sensitive drugs, ensuring product integrity during transportation.
-
Personalized Medicine:
- Shift in Healthcare: The rise of personalized medicine and targeted therapies has introduced complexities in clinical trial logistics, requiring more specialized and flexible infrastructure.
- Temperature-Controlled Logistics: Emphasized for maintaining the stability and efficacy of targeted therapies, involving stringent handling and storage requirements.
-
Market Segmentation:
- By Service: Logistics & distribution, storage & retention, packaging & labeling, manufacturing, comparator sourcing, and other services.
- By Therapeutic Area: Oncology, cardiovascular diseases, respiratory diseases, CNS and mental disorders, and others.
- By Phase: Phase I, Phase II, Phase III, and Phase IV.
- By Country: United States, Canada, and Mexico.
-
Key Market Players: Companies like Thermo Fisher Scientific, Catalent, Parexel, Almac Group, Marken LLC, Piramal Pharma Solutions, DHL, FedEx, and others are major players in the market.
{This summary covers the key facts and insights from the original article, offering information about North American logistics forecasts.}
Source: https://www.globenewswire.com/news-release/2024/08/27/2936447/0/en/North-America-Clinical-Trial-Supply-Logistics-Market-Analysis-Competition-Forecasts-Opportunities-2019-2023-2024-2029.html